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Abstract
Background Erdheim-Chester disease (ECD) is a rare, non-
Langerhans cell histiocytosis with characteristic radiological
and histological features. This entity is defined by a mononu-
clear infiltrate consisting of lipid-laden, foamy histiocytes that
stain positively for CD68 and negatively for CD1a. Osseous
involvement is constant and characteristic. Extra-osseous le-
sions may affect the retroperitoneum, lungs, skin, heart, brain
and orbits.
Methods Both radiography and technetium-99m bone scin-
tigraphy may reveal osteosclerosis of the long bones, which is
a typical finding in ECD. For visceral involvement, computed
tomography (CT) is most useful, while magnetic resonance
(MR) imaging is more sensitive for cardiovascular lesions;
2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG) positron
emission tomography (PET)/CT scanning is useful in
assessing the extension of ECD lesions.
Results The prognosis is extremely variable and is often
worse when there is cardiovascular system involvement. Di-
agnosis is based on the combination of radiographic, CT, MR
imaging and nuclear medicine features and a nearly pathogno-
monic immunohistochemical profile.
Conclusion The aims of this work are to perform a systematic
review of Erdheim-Chester disease as seen on imaging of the
chest, abdomen and musculoskeletal system and to discuss the
diagnostic workup and differential diagnoses according to the
imaging presentation.
Teaching points
• Bone involvement is usually present in patients, and the
imaging findings are pathognomonic of ECD.
• The circumferential periaortic infiltration may extend to its
branches, sometimes becoming symptomatic.
• Cardiac involvement—the pericardium, right atrium and
auriculoventricular sulcus—worsens its prognosis.
• Perirenal infiltration extending to the proximal ureter is
highly suggestive of this disease.
Keywords Erdheim-Chester disease . Osteoclerosis . Hairy
kidney sign . Coated aorta
Abbreviations
ECD Erdheim-Chester disease
FDG 2-[Fluorine-18] fluoro-2-deoxy-d-glucose
PET positron emission tomography
LCH Langerhans cell histiocytosis
Introduction
ECD is a rare, non-familiar disorder, first described by Jakob
Erdheim and William Chester in 1930 as "lipid granulomato-
sis” [1]. By January 2011, approximately 400 distinct cases
had been reported in the medical literature [2].
This disease usually occurs in middle-aged to older pa-
tients, with some possible cases described in the paediatric
population, and has a slight male predominance [3–5]. Its
aetiology and pathogenesis remain unknown because of the
rarity of the disease [6], but a hereditary origin or infectious
process has been excluded [4]. Recently, several researchers
have demonstrated that an abnormal increase in the Th1
immune response, producing several proinflammatory cyto-
kines, namely interferon-a, interleukin-12 and monocyte che-
motactic protein-1, is probably responsible for the recruitment
and activation of the histiocytes in the tissues, ruling out the
hypothesis of the monoclonal proliferation of these cells [4].
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The clinical manifestations in ECD are nonspecific and
depend on the affected organ being asymptomatic, clinically
indolent or sometimes life threatening [4].
Although recent advances in treatment have decreased the
morbidity, the prognosis is still quite poor and the majority of
patients die within 3 years from renal, cardiovascular, pulmo-
nary or central neurological complications [7].
In this article, we performed a systematic review of
Erdheim-Chester disease as seen on computed tomography
(CT), magnetic resonance (MR) imaging or 2-[fluorine-18]
fluoro-2-deoxy-d-glucose (FDG) positron emission tomogra-
phy (PET)/CT imaging of the chest, abdomen and musculo-
skeletal system. We also discussed the diagnostic workup and
differential diagnosis based on imaging findings.
Bone
Bone involvement is almost universal in ECD (96 % of cases)
[4, 5], and more than 50 % of cases have at least one associ-
ated extraskeletal involvement [5], namely the kidney, skin,
Fig. 1 a AP radiographs of the
distal femora in a 39-year-old
female. Bone involvement is
bilateral and symmetric with
diaphyseal and metaphyseal
heterogeneous osteosclerosis.
Distal femora are enlarged, and
periostitis is visible as a wavy
contour (arrows) of the outer
cortex. Corticomedullary margins
in the diaphysis are blurred. b AP
radiograph of two legs in the same
patient. Both tibiae and peronei
are involved. Corticomedullary
margins in the diaphysis are
blurred, and the marrow cavity is
obliterated. Periostitis is also
present (arrows)
Fig. 2 a Coronal T1-weighted
spin-echo and b coronal T2-
weghted spin-echo MR images of
both legs in a 38-year-old female.
There is symmetric low signal
intensity of the diaphyses and
metaphyses, sparing the epiphysis
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central nervous system or heart. Patients may have bone pain,
frequently juxta-articularly at the knees and ankles.
The imaging findings are generally typical and considered
pathognomonic. The disease essentially affects the long bones
and only rarely the axial skeleton [7, 4].
The lower extremities are more commonly affected,
and the disease manifests as a bilateral and symmetric
cortical sclerosis associated with a homogeneous or
heterogeneous sclerosis of the cancellous bone at the
diaphyseal and metaphyseal regions, classically sparing
the epiphyses (Fig. 1) [5]. Rarely, these alterations may
be associated with periostitis and endosteal thickening
(Fig. 1) [6, 8, 9].
On MR, skeletal involvement consists of extensive
replacement of the fatty marrow by low signal on
T1WI, heterogeneous signal on T2WI/STIR and en-
hancement after gadolinium injection (Fig. 2). MRI is
useful to evaluate the extent of medullary bone disease
and diagnose the presence of associated osteonecrosis
[9, 10].
On technetium-99m bone scintigraphy, ECD also has pa-
thognomonic features, namely the intense symmetric activity
of the appendicular skeleton without reaching the epiphyseal
regions (Fig. 3) [9].
FDG PET/CT scan reveals typical bilateral and symmetric
uptake of FDG in the long bones, similar to that observed with
radiography and 99mTc bone scintigraphy (Fig. 4). This im-
aging technique has the advantage of performing an accurate
evaluation of the extent of both the skeletal and extraskeletal
disease [11].
Osteosclerosis is the most common manifestation of this
disease, but rarely there is a mixed pattern with lytic and
sclerotic lesions, hindering the differential diagnosis with
Langerhans cell histiocytosis (LCH) [4, 5] and Paget’s
disease. Nevertheless, in LCH, the presence of sharply
defined lytic lesions in the axial skeleton, namely in the
spine, skull and mandible [28], is characteristic, and in
Paget’s disease, areas beyond the axial skeleton are quite
often affected; the involvement of the appendicular skeleton is
often asymmetric [29].
Taking into account the age group and the sclerotic bone
changes, myelofibrosis, renal osteodystrophy, osteoblastic
metastases and chronic focal osteomyelitis are acquired syn-
dromes that may mimick ECD radiographically [4, 29], thus
being very important in the clinical and laboratory test corre-
lation for making the correct diagnosis.
Other differential diagnoses of bone disease include
hereditary sclerosing bone disease, namely progressive
diaphyseal dysplasia [29], characterised by endostealFig. 3 Coronal 99mTc bone scan images in a 71-year-old female. There
is elevated metabolic activity in the long bones of the lower limbs, sparing
the epiphysis, more exuberant in tibiae (arrows)
Fig. 4 Axial FDG-PET/CT fusion images in a 71-year-old female show-
ing elevated metabolic activity and medullary sclerosis in the long bones
of the distal lower limbs (arrows)
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and periosteal thickening and narrowing of the marrow
cavity, and intramedullary osteosclerosis [29], which
shows unilateral or bilateral asymmetric endosteal thick-
ening confined to the diaphysis of the long bones.
However, these are usually detected in young people.
Renal and perirenal involvement
The kidneys and retroperitoneum are involved in approxi-
mately 68 % of cases [4], being probably the most common
extraosseous localisation.
Fig. 5 Reformatted axial (a),
coronal (b) and sagittal (c, d)
enhanced CT images in a 73-year-
old female showing bilateral and
symmetric perirenal infiltration
(arrow) and bilateral adrenal
thickening (green arrow). Note
also the periaortic concentric soft
tissue infiltration (arrow) and
aortic aneurysm
Fig. 6 Axial enhanced CT
images on a lower (a) and higher
(b) abdominal level and coronal
HASTE (c) and axial T1 post-
gadolinium (d) MRI images in a
71-year-old female showing
bilateral and symmetric
infiltration of the renal sinuses,
with mild hydronephrosis
(arrows). Note also the periaortic
concentric soft tissue infiltration
(arrow)
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Fig. 7 Axial CT-enhanced
images in a 73-year-old male
showing bilateral and diffuse
thickening of the right (a) and left
(b) adrenal glands (arrow).
Periaortic concentric soft tissue
infiltration is visible (arrow).
Axial CT-enhanced (a) and axial
T1 post-gadolinium (b) images in
a 71-year-old female also
showing diffuse thickening of the
left adrenal gland (arrow)
Fig. 8 Axial and sagittal
enhanced reformatted CT images
of the thoracic aorta in a 73-year-
old male showing periaortic
infiltration (arrows) extending
from the aortic root (c) to the
descending aorta (a) and
circumferentially involving the
ascending aorta (a) and aortic
arch (b)
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Patients are mostly asymptomatic and do not present alter-
ations in the routine blood test [7].
On sectional imaging, the hairy kidney sign—a symmetric
and bilateral irregular soft-tissue infiltration of both the
perirenal and posterior pararenal space—is highly suggestive
of this condition (Fig. 5) [12]. These infiltrations can extend to
the renal sinuses and proximal ureters, causing pyelocaliceal
dilatation and consequently abdominal pain and chronic renal
insufficiency (Fig. 6) [13]. On CT, this manifests as a
hypoattenuated and homogeneous band, with spiculated con-
tours and weak contrast enhancement (Figs. 5 and 6). On MR
imaging, it is isointense to muscle on T1- and T2-weighted
sequences, with a slight and homogeneous enhancement after
gadolinium injection (Fig. 6) [14].
The major differential diagnosis is retroperitoneal fibrosis,
either primary or secondary, because all these diseases pro-
duce hydronephrosis by encasement of the collecting system.
In ECD, the renal pelvis and proximal ureter are the portions
generally obstructed by the retroperitoneal infiltrative tissue,
whereas in retroperitoneal fibrosis, the distal pelvic ureters are
more frequently infiltrated and also medially retracted. On the
other hand, contrary to ECD, retroperitoneal fibrosis does not
involve the perirenal space and spares the posterior aortic
wall, but it may compress the inferior vena cava [30].
Adrenal fossa involvement
Retroperitoneal involvement frequently includes a bilat-
eral, symmetric and diffuse thickening of the adrenal
glands associated with infiltration of the adjacent fat
(Figs. 5 and 7). Nevertheless, theses alterations rarely
cause adrenal insufficiency [4, 15].
Aorta and aortic branches
The aorta is the vascular structure more commonly affected
by this disease, and its involvement when diffuse looks
like a regular circumferential periaortic infiltration, giving the
appearance of a “coated aorta” [16]. However, the aorta
may only be affected in a specific segment, symmetrically or
asymmetrically [4]. This infiltration is preferentially peri-
adventitial rather than parietal (Figs. 8, 9 and 10) [17]
and may extend to the aortic branches (Fig. 9c), involving
ostial segments of the supra-aortic, intercostal and coronary
arteries [16] (Fig. 13) in the thorax and celiac trunk, renal
and mesenteric arteries in the abdomen. This ostial extension,
when severe, may cause arterial stenosis/occlusion, and con-
sequently ischaemic changes in the respective organs [7]
responsible for the symptoms—cerebral ischaemic events,
Fig. 9 Axial CT-enhanced (a)
and axial HASTE MR (b) images
of the mediastinum and axial MIP
CT (c) image of the upper
abdomen in a 73-year-old male.
There is periaortic and
mediastinal soft tissue infiltration
(arrow) and also infiltration of the
origin of the renal arteries
(arrows) and of the left renal
sinus, with mild hydronephrosis
(arrow)
Fig. 10 Axial FDG-PET/CT
fusion images in a 71-year-old
female, in the upper (a) and mid
(b) portion of the thorax, showing
elevated metabolic activity
involving the aortic arch (arrow)
and descending aorta (arrow)
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arterial hypertension, cardiac insufficiency and abdominal
angina. This infiltration has the same density and signal
as that observed in the perirenal location: hypoattenuated
on CT and isointense to muscle on T1 and T2 MR imaging,
with weak contrast enhancement (Figs. 8, 9 and 10). On FDG
PET/CT, it also has hypermetabolic activity (Fig. 10) [12].
Takayasu’s disease and retroperitoneal fibrosis constitute
the main differential diagnosis. Takayasu’s disease differs
from ECD by affecting the entire arterial wall, causing con-
centric thickening and conditioning thrombosis, stenosis and
occlusion, vessel ectasia, aneurysms and ulcers [31].
Heart and Pericardium
Heart involvement occurs in 75 % of patients, may be symp-
tomatic or not [18], and, in most cases, presents with ECG and
imaging alterations [5]. It is very important to check the
cardiovascular system in these patients because it carries the
worst prognosis, with death occurring in nearly 60 % because
of complications, namely severe arrhythmias, cardiomyopa-
thy, myocardial infarction or valve insufficiency [5, 19]. Peri-
cardium is the structure most commonly affected, presenting
with smooth soft tissue thickening or effusion (Figs. 11 and
12) and sometimes leading to cardiac tamponade, which is
fatal if not treated. Infiltration of the myocardium shows a
predilection for right heart cavities, specifically the right atri-
um [5] and auriculoventricular sulcus [4], presenting frequent-
ly in the first location as a mural mass and simulating a
tumoral—“pseudo-tumoral”—infiltration (Fig. 13). FDG
PET/CT shows abnormal FDG accumulation in a pseudo-
tumoral formation in the right atriumwith thickened interatrial
septum and involvement of the pericardium (Fig. 14).
Fig. 11 Axial enhanced CT images of the thorax in a 73-year-old male
showing hypodense soft tissue infiltration of the pericardium (arrows)
Fig. 12 Axial enhanced CT images of the thorax in a 71-year-old female
showing pericardial fluid (arrow) and periaortic infiltration (arrows)
Fig. 13 Axial HASTE (a), T1 (b) and four-chamber SSFP (c) cardiac
MR images in a 71-year-old female, showing hypointense soft tissue
infiltration of the right atrium and right atrio-ventricular sulcus (white
arrrow), periarterial infiltration of the right coronary artery (green arrow)
and periaortic infiltration (white arrow)
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Lung parenchyma and pleura
High-resolution (HR) CT scans of the chest reveal involve-
ment of the lung parenchyma and the pleura in 40 to 50 % of
cases [20], but these alterations generally do not substantially
affect the disease prognosis [4]. Patients are frequently asymp-
tomatic or have some dyspnoea or dry cough and only rarely
progress to respiratory insufficiency [4].
Pulmonary involvement in ECD has unspecific features but
is very suggestive of the diagnosis in the appropriate context:
smooth thickening of the pleura and fissures, usually bilateral
and relatively symmetric ± pleural effusion, smooth septal
thickening (Fig. 15a), small centrilobular nodules (Fig. 15b),
parenchymal consolidation, cystic lesions and mosaic ground-
glass opacities (Fig. 15c) [4, 21].
Initial pulmonary Langerhans cell histiocytosis may be
difficult to differentiate from ECD because of the pres-
ence of septal thickening and nodules. Evidence of bi-
zarrely shaped cysts and the typical evolution and distri-
bution of LCH, from reticulo-nodular opacities to cysts,
which tend to be most numerous in the upper and middle
lung zones and spare the lung bases, is key to the
differential diagnosis [32].
Cardiogenic interstitial oedema, sarcoidosis and pulmo-
nary venoocclusive disease, other causes of septal thick-
ening, must be differentiated from ECD. In cardiogenic
interstitial oedema, although septal thickening may be
smooth, centrilobular nodular opacities are unusual. In
pulmonary sarcoidosis, septal thickening is usually nodu-
lar and is characteristic of the presence of adenopathy. In
pulmonary venooclusive disease, there is similar smooth
septal thickening, associated however with signs of pul-
monary hypertension, such as enlargement of the central
pulmonary arteries [33].
Unusual localisations
Involvement of the breast [22], skeletal muscle [6, 22], liver
[23], biliary ducts [24], mesentery [25], gastrointestinal tract
[26] and testes [27] is extremely rare in ECD and only de-
scribed in clinical reports.
Fig. 14 Axial FDG-PET/CT fusion images in a 71-year-old female,
showing pericardial and epicardial thickening, with elevated metabolic
activity, namely in the right atrium and atrio-ventricular sulcus (arrows)
Fig. 15 Several patterns of lung infiltration in high-resolution CT scans.
a A 73-year-old male with bilateral smooth thickening of the interlobular
septa at the lung apices (arrows); b a 39-year-old female with small
centrilobular nodules at the mid-portion of the lungs; c a 71-year-old
female with patchy areas of ground-glass attenuation at the lung apices
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Making the diagnosis of ECD
The diagnosis of ECD can be made with near certainty ac-
cording to its characteristic imaging findings. The bilateral
diffuse or patchy symmetric osteosclerosis of the major long
bones, with relative epiphyseal sparing, associated with
perirenal disease or aortic perivascular thickening, is virtually
pathognomonic for ECD. However, the definitive diagno-
sis is made according to its distinct histological findings
[4]. Biopsy samples from the involved organs, preferen-
tially bony and retroperitoneal infiltration [4], will reveal
diffuse xanthogranulomatous infiltration with foamy his-
tiocytes, inflammatory and Touton giant cells surrounded
by fibrosis. Immunohistochemistry of the biopsy samples
confirms the monocyte/macrophage lineage of the histio-
cytes by their expression of CD68, lysozymes and CD4
and distinguishes them from the Langerhans cell type by
the lack of the CD1a and S100 protein markers. Electron
microscopic findings strengthen the immunostaining results
and confirm the non-Langerhans cell type by lack of Birbeck
granules in their ultrastruture [4, 5].
Role of imaging
Since the outcome of ECD is related to the visceral involvement,
particularly cardiovascular and pulmonary, following the estab-
lishment of the diagnosis, it is essential to assess the presence of
visceral involvement using CT, MRI and/or FDG-PET/CT.
Radiographic evaluation of the long bones is essential for the
workup of this condition [9]. Bone scintigraphy allows a global
evaluation of skeletal abnormalities, which helps to detect
radiographically and clinically silent bone involvement [34].
CT and HRCT are useful for better detection and charac-
terisation of lung, pleural, aortic and skeletal abnormalities.
CT is also the technique more commonly used for image-
guided biopsy [21].
MR imaging is the best technique for the detection and
characterisation of cardiac and pericardial abnormalities [19].
MR imaging of the abdomen remains an alternative in patients
with contraindications to iodinated IV contrast media.
Finally, FDG PET/CT has the main benefit of simul-
taneously evaluating the extent of the skeletal and
extraskeletal disease, detecting occult visceral and vascular
involvement and following its evolution and the response to
treatment [4, 11].
Conclusions
The manifestations in Erdheim-Chester disease are diverse
and nonspecific, and patients may go years before they get a
correct diagnosis.
Symmetric osteosclerosis of the long bones involving the
metaphyses and diaphyses but sparing the epiphyses is the
most characteristic finding. The disease may also affect the
central nervous system, heart, pericardium, lungs and kidneys,
retroperitoneal and retro-orbital tissue.
The number of new cases has dramatically increased over
the past years because of the better recognition of this condi-
tion. The natural evolution is variable but the spontaneous
prognosis is severe. A good knowledge of its specific imaging
features seems to be crucial for early management and im-
proved prognosis.
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